# Research Idea: GenAI-ViL Framework for Efficient Generative Medical AI Validation

## Title
Validation-in-the-Loop (GenAI-ViL): A Three-Stage Framework for Cost-Effective Clinical Validation of Generative Medical AI Models

## Motivation
Generative AI models hold transformative potential for healthcare through synthetic medical data generation and image synthesis, yet clinical deployment remains limited. A critical barrier is validation cost: traditional ad-hoc approaches require ~100 expert hours per model with fragmented methodologies lacking regulatory acceptance. Current frameworks propose validation structures but lack practical implementation pathways. This creates an economic bottleneck preventing adoption, particularly in resource-constrained settings serving underrepresented populations (pediatrics, rare diseases, critical care).

## Main Idea
We propose GenAI-ViL, a three-stage validation framework that reduces validation costs by 40-60% while maintaining clinical safety (False Negative Rate <5%). The framework implements a validation efficiency cascade: **Loop 1 (Data-in-Loop)** uses automated metrics (FID, SSIM, Hellinger distance, biomarker preservation) to filter 50-70% of inadequate models before expert review; **Loop 2 (Clinician-in-Loop)** applies stratified sampling targeting threshold boundaries and contradictory metrics, achieving 95% validation accuracy while reviewing only 20-40% of passing models; **Loop 3 (Deployment-in-Loop)** enables federated learning-compatible continuous monitoring across institutions, detecting performance drift >10% before clinical harm. 

We will validate through paired comparison (n≥20 models) comparing GenAI-ViL versus traditional validation, measuring cost reduction and safety. A Phase 0 pilot (50 images, 3 experts) will first establish automated-to-clinical metric correlation ≥0.7, the critical assumption enabling the efficiency cascade. Success creates regulatory-grade validation with economic adoption incentives beyond compliance mandates.